Use of Neuroenhancement Drugs: Prevalence, Frequency and Use Expectations in Switzerland
Deline, S.; Baggio, S.; Studer, J.; N'Goran, A.A.; Dupuis, M.; Henchoz, Y.; Mohler-Kuo, M.; Daeppen, J.-B.; Gmel, G. Use of Neuroenhancement Drugs: Prevalence, Frequency and Use Expectations in Switzerland. Int. J. Environ. Res. Public Health 2014, 11, 3032-3045. https://doi.org/10.3390/ijerph110303032
Deline S, Baggio S, Studer J, N'Goran AA, Dupuis M, Henchoz Y, Mohler-Kuo M, Daeppen J-B, Gmel G. Use of Neuroenhancement Drugs: Prevalence, Frequency and Use Expectations in Switzerland. International Journal of Environmental Research and Public Health. 2014; 11(3):3032-3045. https://doi.org/10.3390/ijerph110303032
Chicago/Turabian StyleDeline, Stéphane, Stéphanie Baggio, Joseph Studer, Alexandra A. N'Goran, Marc Dupuis, Yves Henchoz, Meichun Mohler-Kuo, Jean-Bernard Daeppen, and Gerhard Gmel. 2014. "Use of Neuroenhancement Drugs: Prevalence, Frequency and Use Expectations in Switzerland" International Journal of Environmental Research and Public Health 11, no. 3: 3032-3045. https://doi.org/10.3390/ijerph110303032